376 related articles for article (PubMed ID: 11058869)
1. Expression of a catalytically inactive H118Y mutant of nm23-H2 suppresses the metastatic potential of line IV Cl 1 human melanoma cells.
Hamby CV; Abbi R; Prasad N; Stauffer C; Thomson J; Mendola CE; Sidorov V; Backer JM
Int J Cancer; 2000 Nov; 88(4):547-53. PubMed ID: 11058869
[TBL] [Abstract][Full Text] [Related]
2. Differential expression and mutation of NME genes in autologous cultured human melanoma cells with different metastatic potentials.
Hamby CV; Mendola CE; Potla L; Stafford G; Backer JM
Biochem Biophys Res Commun; 1995 Jun; 211(2):579-85. PubMed ID: 7794272
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of N-acetylglucosaminyltransferase V by tumorigenesis- or metastasis-suppressor gene and its relation to metastatic potential of human hepatocarcinoma cells.
Guo HB; Liu F; Zhao JH; Chen HL
J Cell Biochem; 2000 Sep; 79(3):370-85. PubMed ID: 10972975
[TBL] [Abstract][Full Text] [Related]
4. A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential.
MacDonald NJ; De la Rosa A; Benedict MA; Freije JM; Krutsch H; Steeg PS
J Biol Chem; 1993 Dec; 268(34):25780-9. PubMed ID: 8245015
[TBL] [Abstract][Full Text] [Related]
5. [Expression and anti-metastatic potential of nm 23/NDP kinase in human head and neck cancer cells].
Miyazaki H
Kokubyo Gakkai Zasshi; 1998 Jun; 65(2):189-95. PubMed ID: 9711037
[TBL] [Abstract][Full Text] [Related]
6. Two isotypes of murine nm23/nucleoside diphosphate kinase, nm23-M1 and nm23-M2, are involved in metastatic suppression of a murine melanoma line.
Baba H; Urano T; Okada K; Furukawa K; Nakayama E; Tanaka H; Iwasaki K; Shiku H
Cancer Res; 1995 May; 55(9):1977-81. PubMed ID: 7728768
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of nm23-H2/NDP kinase B in a human oral squamous cell carcinoma cell line results in reduced metastasis, differentiated phenotype in the metastatic site, and growth factor-independent proliferative activity in culture.
Miyazaki H; Fukuda M; Ishijima Y; Takagi Y; Iimura T; Negishi A; Hirayama R; Ishikawa N; Amagasa T; Kimura N
Clin Cancer Res; 1999 Dec; 5(12):4301-7. PubMed ID: 10632374
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory activity of nm23-H1 on invasion and colonization of human prostate carcinoma cells is not mediated by its NDP kinase activity.
Lee HY; Lee H
Cancer Lett; 1999 Oct; 145(1-2):93-9. PubMed ID: 10530775
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of NM23-1 enhances responsiveness of IMR-32 human neuroblastoma cells to differentiation stimuli.
Backer MV; Kamel N; Sandoval C; Jayabose S; Mendola CE; Backer JM
Anticancer Res; 2000; 20(3A):1743-9. PubMed ID: 10928103
[TBL] [Abstract][Full Text] [Related]
10. Nucleoside diphosphate kinase enzyme activity of NM23-H2/PuF is not required for its DNA binding and in vitro transcriptional functions.
Postel EH; Ferrone CA
J Biol Chem; 1994 Mar; 269(12):8627-30. PubMed ID: 8132589
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of nucleoside diphosphate kinase alpha isoform, an nm23-H2 gene homolog, is associated with metastatic potential of rat mammary-adenocarcinoma cells.
Fukuda M; Ishii A; Yasutomo Y; Shimada N; Ishikawa N; Hanai N; Nagata N; Irimura T; Nicolson GL; Kimura N
Int J Cancer; 1996 Feb; 65(4):531-7. PubMed ID: 8621239
[TBL] [Abstract][Full Text] [Related]
12. nm23-H1 reduces in vitro cell migration and the liver metastatic potential of colon cancer cells by regulating myosin light chain phosphorylation.
Suzuki E; Ota T; Tsukuda K; Okita A; Matsuoka K; Murakami M; Doihara H; Shimizu N
Int J Cancer; 2004 Jan; 108(2):207-11. PubMed ID: 14639604
[TBL] [Abstract][Full Text] [Related]
13. Nm23 and tumour metastasis: basic and translational advances.
Freije JM; MacDonald NJ; Steeg PS
Biochem Soc Symp; 1998; 63():261-71. PubMed ID: 9513729
[TBL] [Abstract][Full Text] [Related]
14. [Expression of nm23/NDPK, integrin, type IV collagenase and uPA in transplanted tumors with various metastatic potential in nude mice and surgical specimens].
Wei H; Wu F; Zhou J
Zhonghua Yi Xue Za Zhi; 1997 Aug; 77(8):597-600. PubMed ID: 9772466
[TBL] [Abstract][Full Text] [Related]
15. Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells.
Leone A; Flatow U; King CR; Sandeen MA; Margulies IM; Liotta LA; Steeg PS
Cell; 1991 Apr; 65(1):25-35. PubMed ID: 2013093
[TBL] [Abstract][Full Text] [Related]
16. Site-directed mutation of Nm23-H1. Mutations lacking motility suppressive capacity upon transfection are deficient in histidine-dependent protein phosphotransferase pathways in vitro.
Freije JM; Blay P; MacDonald NJ; Manrow RE; Steeg PS
J Biol Chem; 1997 Feb; 272(9):5525-32. PubMed ID: 9038158
[TBL] [Abstract][Full Text] [Related]
17. A novel function for the nm23-H1 gene: overexpression in human breast carcinoma cells leads to the formation of basement membrane and growth arrest.
Howlett AR; Petersen OW; Steeg PS; Bissell MJ
J Natl Cancer Inst; 1994 Dec; 86(24):1838-44. PubMed ID: 7990158
[TBL] [Abstract][Full Text] [Related]
18. Nm23/nucleoside diphosphate kinase in human cancers.
Hartsough MT; Steeg PS
J Bioenerg Biomembr; 2000 Jun; 32(3):301-8. PubMed ID: 11768314
[TBL] [Abstract][Full Text] [Related]
19. A novel serine/threonine-specific protein phosphotransferase activity of Nm23/nucleoside-diphosphate kinase.
Engel M; Véron M; Theisinger B; Lacombe ML; Seib T; Dooley S; Welter C
Eur J Biochem; 1995 Nov; 234(1):200-7. PubMed ID: 8529641
[TBL] [Abstract][Full Text] [Related]
20. Point mutations affecting the oligomeric structure of Nm23-H1 abrogates its inhibitory activity on colonization and invasion of prostate cancer cells.
Kim YI; Park S; Jeoung DI; Lee H
Biochem Biophys Res Commun; 2003 Jul; 307(2):281-9. PubMed ID: 12859952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
